Frequently asked questions
Straight answers about what BioTekk does and does not do
These answers are deliberately concise. Each links to the platform, safety, technology or privacy pages where the detail lives. If something you need is missing, ask us directly.
BioTekk is developing an AI-enabled mental-health support and intelligence platform. It is intended to help individuals reflect on their wellbeing and help authorised professionals and organisations understand relevant changes over time. See the platform overview →
No. BioTekk is an AI-enabled technology platform and should not be represented as a human therapist. It does not replace professional assessment, diagnosis or treatment. How the conversational layer is bounded →
BioTekk is in active development. Availability will depend on the product configuration, pilot programme and location. Contact BioTekk for current participation opportunities.
No independent diagnostic claim should be made. BioTekk may help users describe experiences and identify patterns, but diagnosis requires an appropriately qualified professional using a suitable assessment process. Read how intended purpose is defined →
The platform is being designed to recognise defined indicators of concern and provide proportionate safety messaging or escalation. BioTekk is not an emergency service, and automated indicators do not replace human assessment. Crisis and safeguarding boundaries →
Wearable and biometric integration forms part of the research and development roadmap. Availability will depend on consent, validation, device compatibility and the intended use of the deployment. Individual biometric signals will not be presented as independent evidence of a mental-health condition. Read the biometric position →
BioTekk’s recommended organisational model does not provide managers with individual conversation content. Any organisational reporting should be aggregated, access-controlled and governed by clear privacy arrangements. How roles and access are separated →
BioTekk is being designed with interoperability in mind. Compatibility with a specific system should be confirmed only after technical implementation, supplier engagement, testing and local approval. Read the integration approach →
BioTekk is being developed with UK data-protection requirements in mind. Compliance is an ongoing organisational and technical responsibility and must be assessed for each relevant processing activity and deployment. Read the privacy notice →
The proposed evaluation framework includes safety testing, response-quality assessment, false-positive and false-negative analysis, subgroup performance, robustness, usability, accessibility and monitoring after deployment. See the evaluation framework →
Contact BioTekk with information about your organisation, population, current pathway, objectives, governance contacts and preferred timescale. Start a pilot enquiry →
Qualified investors may request the current investor materials through the Investors page or by contacting BioTekk directly.
Where this site says “is designed to”, “is intended to” or “may”, it describes design intent during active development rather than a delivered, validated capability. We use that language deliberately, because in mental-health technology the difference matters.
Still have
a question?
Clinical, technical, governance or commercial — send it to us directly and we will answer it properly rather than generically.